A detailed history of First Republic Investment Management, Inc. transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 15,979 shares of ITOS stock, worth $131,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,979
Previous 15,979 -0.0%
Holding current value
$131,507
Previous $211,000 17.54%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$13.02 - $22.62 $62,821 - $109,141
-4,825 Reduced 23.19%
15,979 $217,000
Q2 2022

Aug 16, 2022

SELL
$16.57 - $35.1 $347 - $737
-21 Reduced 0.1%
20,804 $429,000
Q1 2022

May 16, 2022

SELL
$31.92 - $47.45 $89,120 - $132,480
-2,792 Reduced 11.82%
20,825 $670,000
Q4 2021

Feb 09, 2022

BUY
$26.23 - $47.86 $619,473 - $1.13 Million
23,617 New
23,617 $1.1 Million

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $293M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.